Emmanuel Macron and Marine Le Pen to face each other in runoffWorld April 24, 8:13
Danish defense minister accuses Russians of hacking into his staff’s emailsWorld April 24, 7:50
PROFILE: Emmanuel Macron poised to become France’s youngest presidentWorld April 24, 6:44
North Korea ready to carry out nuclear test at any time — expertsWorld April 24, 5:56
Swedish think tank puts Russia in world’s top three biggest defense spendersMilitary & Defense April 24, 4:35
Ukraine reconciliation meeting in Minsk postponed over OSCE car blastWorld April 24, 3:21
Macron announces his victory in first round of French presidential voteWorld April 24, 1:29
Le Pen gets 23.08%, Macron - 23.11% after 33 mln votes counted — Interior MinistryWorld April 23, 23:58
Preliminary results of French polls reveal defeat of two leading partiesWorld April 23, 22:49
MOSCOW, March 17. /TASS/. The World Anti-Doping Agency (WADA) still has not answered to the Latvian pharmaceutical firm Grindex why the company’s produced mildronate was included in the list of the banned substances, Grindex spokeswoman Laila Klavina told TASS on Thursday.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016.
"It was last summer, when Grindex jointly with the Anti-Doping Department of the Latvian State Center for Athletics Medicine provided WADA with all arguments, proof and reasoning why the drug should not be included in the list of the banned substances," Klavina said in an interview with TASS.
"There was still no information from WADA last autumn, when it became obvious that meldonium would be on the list," she added. "All we know as of now is that meldonium on the list of the banned substances. Meanwhile, there is still no response from WADA."
Last week Grindex announced on its website that "Mildronate is widely used in the clinical practice."
"During increased physical activity, it restores the oxygen balance of tissue cells as well as it activates the metabolic processes that results in lower requirements of oxygen consumption for energy production," according to Grindex. "Mildronate is widely recognized by health care professionals and patients, and this may include athletes as well."
Russian sports was hit last week by a new case in a chain of doping-related scandals after some of the country’s athletes tested positive for banned substance meldonium.
After the drug meldonium (mildronate) was included in WADA’s list of banned substances a number of Russian athletes tested positive for the banned substance.
Those who have proved to have used meldonium since are cyclist Eduard Vorganov, figure skater Yekaterina Bobrova, tennis player Maria Sharapova, skater Pavel Kulizhnikov, short-track skaters Semion Elistratov and Ekaterina Konstantinova, volleyball player Aleksandr Markin and biathlete Eduard Latypov.
The number of athletes from Russia as well as worldwide testing positive for banned meldonium keeps rising.
The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).